annual EBITDA:
$600.00M-$316.70M(-34.55%)Summary
- As of today (June 2, 2025), DXCM annual EBITDA is $600.00 million, with the most recent change of -$316.70 million (-34.55%) on December 31, 2024.
- During the last 3 years, DXCM annual EBITDA has risen by +$222.40 million (+58.90%).
- DXCM annual EBITDA is now -34.55% below its all-time high of $916.70 million, reached on December 31, 2023.
Performance
DXCM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$219.00M-$55.00M(-20.07%)Summary
- As of today (June 2, 2025), DXCM quarterly EBITDA is $219.00 million, with the most recent change of -$55.00 million (-20.07%) on March 31, 2025.
- Over the past year, DXCM quarterly EBITDA has increased by +$29.40 million (+15.51%).
- DXCM quarterly EBITDA is now -27.87% below its all-time high of $303.60 million, reached on December 31, 2023.
Performance
DXCM quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$975.10M+$29.40M(+3.11%)Summary
- As of today (June 2, 2025), DXCM TTM EBITDA is $975.10 million, with the most recent change of +$29.40 million (+3.11%) on March 31, 2025.
- Over the past year, DXCM TTM EBITDA has dropped by -$20.50 million (-2.06%).
- DXCM TTM EBITDA is now -5.46% below its all-time high of $1.03 billion, reached on June 30, 2024.
Performance
DXCM TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
DXCM EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -34.5% | +15.5% | -2.1% |
| 3 y3 years | +58.9% | +179.7% | +150.0% |
| 5 y5 years | +181.4% | +331.1% | +266.9% |
DXCM EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -34.5% | +58.9% | -27.9% | +179.7% | -5.5% | +151.2% |
| 5 y | 5-year | -34.5% | +181.4% | -27.9% | +415.3% | -5.5% | +266.9% |
| alltime | all time | -34.5% | +903.2% | -27.9% | +236.8% | -5.5% | +1219.5% |
DXCM EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $219.00M(-20.1%) | $975.10M(+3.1%) |
| Dec 2024 | $600.00M(-34.5%) | $274.00M(+15.4%) | $945.70M(-3.0%) |
| Sep 2024 | - | $237.40M(-3.0%) | $975.30M(-5.4%) |
| Jun 2024 | - | $244.70M(+29.1%) | $1.03B(+3.6%) |
| Mar 2024 | - | $189.60M(-37.5%) | $995.60M(+8.6%) |
| Dec 2023 | $916.70M(+62.2%) | $303.60M(+3.4%) | $916.70M(+16.4%) |
| Sep 2023 | - | $293.50M(+40.5%) | $787.30M(+15.1%) |
| Jun 2023 | - | $208.90M(+88.7%) | $683.80M(+14.3%) |
| Mar 2023 | - | $110.70M(-36.5%) | $598.50M(+5.7%) |
| Dec 2022 | $565.30M(+49.7%) | $174.20M(-8.3%) | $566.10M(+30.3%) |
| Sep 2022 | - | $190.00M(+53.7%) | $434.40M(+11.9%) |
| Jun 2022 | - | $123.60M(+57.9%) | $388.20M(-0.5%) |
| Mar 2022 | - | $78.30M(+84.2%) | $390.00M(+3.0%) |
| Dec 2021 | $377.60M(+0.2%) | $42.50M(-70.4%) | $378.60M(-18.1%) |
| Sep 2021 | - | $143.80M(+14.7%) | $462.40M(+5.9%) |
| Jun 2021 | - | $125.40M(+87.4%) | $436.50M(+11.1%) |
| Mar 2021 | - | $66.90M(-47.0%) | $392.90M(+4.3%) |
| Dec 2020 | $376.80M(+76.7%) | $126.30M(+7.1%) | $376.80M(+0.6%) |
| Sep 2020 | - | $117.90M(+44.1%) | $374.40M(+13.4%) |
| Jun 2020 | - | $81.80M(+61.0%) | $330.30M(+24.3%) |
| Mar 2020 | - | $50.80M(-59.0%) | $265.80M(+24.7%) |
| Dec 2019 | $213.20M(-385.4%) | $123.90M(+67.9%) | $213.20M(-401.1%) |
| Sep 2019 | - | $73.80M(+326.6%) | -$70.80M(-18.7%) |
| Jun 2019 | - | $17.30M(-1061.1%) | -$87.10M(+37.6%) |
| Mar 2019 | - | -$1.80M(-98.9%) | -$63.30M(-15.3%) |
| Dec 2018 | -$74.70M(+279.2%) | -$160.10M(-378.4%) | -$74.70M(-172.6%) |
| Sep 2018 | - | $57.50M(+39.9%) | $102.90M(+99.0%) |
| Jun 2018 | - | $41.10M(-411.4%) | $51.70M(+1515.6%) |
| Mar 2018 | - | -$13.20M(-175.4%) | $3.20M(-116.2%) |
| Dec 2017 | -$19.70M(-60.0%) | $17.50M(+177.8%) | -$19.70M(-51.1%) |
| Sep 2017 | - | $6.30M(-185.1%) | -$40.30M(-33.8%) |
| Jun 2017 | - | -$7.40M(-79.5%) | -$60.90M(-12.5%) |
| Mar 2017 | - | -$36.10M(+1064.5%) | -$69.60M(+41.5%) |
| Dec 2016 | -$49.20M(+6.3%) | -$3.10M(-78.3%) | -$49.20M(+18.8%) |
| Sep 2016 | - | -$14.30M(-11.2%) | -$41.40M(-38.0%) |
| Jun 2016 | - | -$16.10M(+2.5%) | -$66.80M(+29.2%) |
| Mar 2016 | - | -$15.70M(-434.0%) | -$51.70M(+11.7%) |
| Dec 2015 | -$46.30M(+253.4%) | $4.70M(-111.8%) | -$46.30M(-1.5%) |
| Sep 2015 | - | -$39.70M(+3870.0%) | -$47.00M(+365.3%) |
| Jun 2015 | - | -$1.00M(-90.3%) | -$10.10M(-22.3%) |
| Mar 2015 | - | -$10.30M(-357.5%) | -$13.00M(-0.8%) |
| Dec 2014 | -$13.10M | $4.00M(-242.9%) | -$13.10M(-25.1%) |
| Sep 2014 | - | -$2.80M(-28.2%) | -$17.50M(-6.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2014 | - | -$3.90M(-62.5%) | -$18.80M(-19.0%) |
| Mar 2014 | - | -$10.40M(+2500.0%) | -$23.20M(+5.9%) |
| Dec 2013 | -$21.90M(-55.3%) | -$400.00K(-90.2%) | -$21.90M(-21.8%) |
| Sep 2013 | - | -$4.10M(-50.6%) | -$28.00M(-28.4%) |
| Jun 2013 | - | -$8.30M(-8.8%) | -$39.10M(-11.1%) |
| Mar 2013 | - | -$9.10M(+40.0%) | -$44.00M(-10.4%) |
| Dec 2012 | -$49.00M(+19.8%) | -$6.50M(-57.2%) | -$49.10M(-8.6%) |
| Sep 2012 | - | -$15.20M(+15.2%) | -$53.71M(+5.8%) |
| Jun 2012 | - | -$13.20M(-7.0%) | -$50.79M(+15.3%) |
| Mar 2012 | - | -$14.20M(+27.8%) | -$44.06M(+7.7%) |
| Dec 2011 | -$40.90M(-20.3%) | -$11.11M(-9.5%) | -$40.90M(+4.9%) |
| Sep 2011 | - | -$12.28M(+89.7%) | -$38.99M(-1.1%) |
| Jun 2011 | - | -$6.47M(-41.4%) | -$39.43M(-10.1%) |
| Mar 2011 | - | -$11.04M(+20.0%) | -$43.86M(-14.5%) |
| Dec 2010 | -$51.30M(+19.0%) | -$9.20M(-27.7%) | -$51.30M(+0.5%) |
| Sep 2010 | - | -$12.73M(+16.7%) | -$51.06M(+3.7%) |
| Jun 2010 | - | -$10.90M(-41.0%) | -$49.23M(-3.5%) |
| Mar 2010 | - | -$18.47M(+106.2%) | -$51.02M(+18.4%) |
| Dec 2009 | -$43.11M(-13.4%) | -$8.96M(-17.8%) | -$43.11M(-7.4%) |
| Sep 2009 | - | -$10.90M(-14.1%) | -$46.53M(-4.6%) |
| Jun 2009 | - | -$12.69M(+20.1%) | -$48.77M(+0.1%) |
| Mar 2009 | - | -$10.56M(-14.7%) | -$48.70M(-2.2%) |
| Dec 2008 | -$49.79M(+14.9%) | -$12.38M(-5.8%) | -$49.79M(+2.8%) |
| Sep 2008 | - | -$13.14M(+4.2%) | -$48.44M(+5.2%) |
| Jun 2008 | - | -$12.62M(+8.3%) | -$46.03M(+4.2%) |
| Mar 2008 | - | -$11.65M(+5.6%) | -$44.16M(+1.9%) |
| Dec 2007 | -$43.34M(-7.0%) | -$11.03M(+2.8%) | -$43.34M(+0.8%) |
| Sep 2007 | - | -$10.73M(-0.2%) | -$43.00M(-6.4%) |
| Jun 2007 | - | -$10.75M(-0.7%) | -$45.92M(-2.5%) |
| Mar 2007 | - | -$10.83M(+1.3%) | -$47.08M(+2.6%) |
| Dec 2006 | -$46.62M(+48.6%) | -$10.69M(-21.8%) | -$45.88M(-3.2%) |
| Sep 2006 | - | -$13.66M(+14.7%) | -$47.40M(+16.7%) |
| Jun 2006 | - | -$11.90M(+23.6%) | -$40.60M(+16.2%) |
| Mar 2006 | - | -$9.63M(-21.1%) | -$34.93M(+13.8%) |
| Dec 2005 | -$31.36M(+131.0%) | -$12.20M(+77.9%) | -$30.69M(+66.0%) |
| Sep 2005 | - | -$6.86M(+10.1%) | -$18.49M(+59.0%) |
| Jun 2005 | - | -$6.23M(+15.6%) | -$11.62M(+115.6%) |
| Mar 2005 | - | -$5.39M | -$5.39M |
| Dec 2004 | -$13.58M(+38.1%) | - | - |
| Dec 2003 | -$9.83M(+55.8%) | - | - |
| Dec 2002 | -$6.31M(-6.1%) | - | - |
| Dec 2001 | -$6.72M(+67.5%) | - | - |
| Dec 2000 | -$4.01M | - | - |
FAQ
- What is DexCom annual EBITDA?
- What is the all time high annual EBITDA for DexCom?
- What is DexCom annual EBITDA year-on-year change?
- What is DexCom quarterly EBITDA?
- What is the all time high quarterly EBITDA for DexCom?
- What is DexCom quarterly EBITDA year-on-year change?
- What is DexCom TTM EBITDA?
- What is the all time high TTM EBITDA for DexCom?
- What is DexCom TTM EBITDA year-on-year change?
What is DexCom annual EBITDA?
The current annual EBITDA of DXCM is $600.00M
What is the all time high annual EBITDA for DexCom?
DexCom all-time high annual EBITDA is $916.70M
What is DexCom annual EBITDA year-on-year change?
Over the past year, DXCM annual EBITDA has changed by -$316.70M (-34.55%)
What is DexCom quarterly EBITDA?
The current quarterly EBITDA of DXCM is $219.00M
What is the all time high quarterly EBITDA for DexCom?
DexCom all-time high quarterly EBITDA is $303.60M
What is DexCom quarterly EBITDA year-on-year change?
Over the past year, DXCM quarterly EBITDA has changed by +$29.40M (+15.51%)
What is DexCom TTM EBITDA?
The current TTM EBITDA of DXCM is $975.10M
What is the all time high TTM EBITDA for DexCom?
DexCom all-time high TTM EBITDA is $1.03B
What is DexCom TTM EBITDA year-on-year change?
Over the past year, DXCM TTM EBITDA has changed by -$20.50M (-2.06%)